Birchview Capital, LP - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$172,800
+73.5%
120,000
+200.0%
0.15%
+96.0%
Q2 2023$99,600
+92984.1%
40,0000.0%0.08%
-10.7%
Q1 2023$107
-50.7%
40,0000.0%0.08%
-45.1%
Q4 2022$217
-100.0%
40,0000.0%0.15%
-56.5%
Q3 2022$500,000
+152.5%
40,0000.0%0.35%
+144.4%
Q2 2022$198,000
-34.9%
40,0000.0%0.14%
-34.2%
Q1 2022$304,000
-25.5%
40,0000.0%0.22%
-16.7%
Q4 2021$408,000
-24.0%
40,0000.0%0.26%
-27.9%
Q3 2021$537,000
-38.8%
40,0000.0%0.36%
-30.5%
Q2 2021$878,000
-8.7%
40,0000.0%0.52%
-8.1%
Q1 2021$962,000
+33.6%
40,0000.0%0.57%
+37.6%
Q4 2020$720,000
-22.1%
40,000
-50.0%
0.42%
+34.3%
Q3 2020$924,000
-4.7%
80,000
+100.0%
0.31%
-47.3%
Q2 2020$970,000
+120.0%
40,0000.0%0.59%
+49.9%
Q1 2020$441,000
-58.3%
40,0000.0%0.39%
-49.1%
Q4 2019$1,057,000
+16.0%
40,0000.0%0.77%
+26.5%
Q3 2019$911,000
-25.7%
40,0000.0%0.61%
-18.6%
Q2 2019$1,226,000
+392.4%
40,000
+166.7%
0.75%
+378.2%
Q1 2019$249,000
-13.2%
15,0000.0%0.16%
-42.4%
Q4 2018$287,000
-63.4%
15,0000.0%0.27%
-46.4%
Q3 2018$784,000
-18.0%
15,000
-31.8%
0.51%
-22.2%
Q2 2018$956,000
+17.3%
22,0000.0%0.65%
+21.0%
Q1 2018$815,00022,0000.54%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders